INHIBITION OF VOLTAGE-GATED CA2+ ENTRY INTO GH3 AND CHROMAFFIN CELLS BY IMIDAZOLE ANTIMYCOTICS AND OTHER CYTOCHROME-P450 BLOCKERS

被引:89
作者
VILLALOBOS, C
FONTERIZ, R
LOPEZ, MG
GARCIA, AG
GARCIASANCHO, J
机构
[1] UNIV VALLADOLID,FAC MED,DEPT BIOQUIM & BIOL MOLEC & FISIOL,VALLADOLID,SPAIN
[2] UNIV AUTONOMA MADRID,FAC MED,DEPT FARMACOL & TERAPEUT,MADRID 34,SPAIN
关键词
CA2+ CHANNELS; CYTOCHROME-P-450; GH3 PITUITARY CELLS; ADRENAL CHROMAFFIN CELLS;
D O I
10.1096/fasebj.6.9.1319362
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have studied the effects of cytochrome P450 inhibitors on the entry of Ca2+ and Mn2+, used here as a Ca2+ surrogate for Ca2+ channels, in fura-2-loaded GH3 pituitary cells and bovine chromaffin cells depolarized with high-K+ solutions. Imidazole antimycotics were potent inhibitors (econazole > miconazole > clotrimazole > ketoconazole). Alpha-naphtoflavone and isosafrole, but not metyrapone, also inhibited the entry of Ca2+ and Mn2+ induced by depolarization. This inhibitory profile most resembles that reported for IA-type cytochrome P450. However, carbon monoxide (CO), a well-known cytochrome P450 antagonist, had no effect on Ca2+ (Mn2+) entry. Given the high selectivity of the imidazole antimycotics for the heme moiety, our results suggest that a hemoprotein closely related to cytochrome P450 (but insensitive to CO) might be involved in the regulation of voltage-gated Ca2+ channels. The inhibitory pattern was also similar to that previously reported for agonist-induced Ca2+ (Mn2+) influx in neutrophils and platelets, although CO was an efficient inhibitor in this case. These results pose the question of whether similarities in the sensitivity to cytochrome P450 inhibitors exhibited by receptor-operated and voltage-gated channels reflect unknown similarities either in structural features or regulation mechanisms.
引用
收藏
页码:2742 / 2747
页数:6
相关论文
共 35 条
[1]   THE METABOLISM OF 2,5-DIPHENYLOXAZOLE (PPO) IN HUMAN-LYMPHOCYTES AND RAT-LIVER MICROSOMES [J].
AHOKAS, JT ;
DAVIES, C ;
JACOBSEN, N ;
KARKI, NT ;
PHILIPPIDES, A ;
TRESTON, AM .
PHARMACOLOGY & TOXICOLOGY, 1987, 61 (03) :184-190
[2]   AGONIST-INDUCED CA2+ INFLUX INTO HUMAN PLATELETS IS SECONDARY TO THE EMPTYING OF INTRACELLULAR CA2+ STORES [J].
ALONSO, MT ;
ALVAREZ, J ;
MONTERO, M ;
SANCHEZ, A ;
GARCIASANCHO, J .
BIOCHEMICAL JOURNAL, 1991, 280 :783-789
[3]   MONITORING OF THE ACTIVATION OF RECEPTOR-OPERATED CALCIUM CHANNELS IN HUMAN-PLATELETS [J].
ALONSO, MT ;
SANCHEZ, A ;
GARCIASANCHO, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 162 (01) :24-29
[4]   ARACHIDONIC ACID-INDUCED CALCIUM INFLUX IN HUMAN PLATELETS - COMPARISON WITH THE EFFECT OF THROMBIN [J].
ALONSO, MT ;
SANCHEZ, A ;
GARCIASANCHO, J .
BIOCHEMICAL JOURNAL, 1990, 272 (02) :435-443
[5]   CYTOCHROME-P450 MAY REGULATE PLASMA-MEMBRANE CA2+ PERMEABILITY ACCORDING TO THE FILLING STATE OF THE INTRACELLULAR CA2+ STORES [J].
ALVAREZ, J ;
MONTERO, M ;
GARCIASANCHO, J .
FASEB JOURNAL, 1992, 6 (02) :786-792
[6]   2 TYPES OF CA2+ CURRENTS ARE FOUND IN BOVINE CHROMAFFIN CELLS - FACILITATION IS DUE TO THE RECRUITMENT OF ONE TYPE [J].
ARTALEJO, CR ;
DAHMER, MK ;
PERLMAN, RL ;
FOX, AP .
JOURNAL OF PHYSIOLOGY-LONDON, 1991, 432 :681-707
[7]   A COMPARATIVE-STUDY OF 1-SUBSTITUTED IMIDAZOLE AND 1,2,4-TRIAZOLE ANTIFUNGAL COMPOUNDS AS INHIBITORS OF TESTOSTERONE HYDROXYLATIONS CATALYZED BY MOUSE HEPATIC-MICROSOMAL CYTOCHROMES-P-450 [J].
BALLARD, SA ;
LODOLA, A ;
TARBIT, MH .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (24) :4643-4651
[8]   2 TYPES OF CALCIUM CHANNELS ARE EXPRESSED IN ADULT BOVINE CHROMAFFIN CELLS [J].
BOSSU, JL ;
DEWAARD, M ;
FELTZ, A .
JOURNAL OF PHYSIOLOGY-LONDON, 1991, 437 :621-634
[9]   INHIBITORS OF CYTOCHROME P-450-DEPENDENT ARACHIDONIC-ACID METABOLISM [J].
CAPDEVILA, J ;
GIL, L ;
ORELLANA, M ;
MARNETT, LJ ;
MASON, JI ;
YADAGIRI, P ;
FALCK, JR .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1988, 261 (02) :257-263
[10]   MULTIPLE ACTIONS OF SC-38249 - THE BLOCKER OF BOTH VOLTAGE-OPERATED AND 2ND MESSENGER-OPERATED CA2+ CHANNELS ALSO INHIBITS CA2+ EXTRUSION [J].
CIARDO, A ;
MELDOLESI, J .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 188 (06) :417-421